Literature DB >> 31567129

Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2.

Sergio Piña-Oviedo1, Cesar A Moran2.   

Abstract

Primary mediastinal non-Hodgkin lymphomas (PM-NHLs) represent ∼5% of all non-Hodgkin lymphomas (NHLs) and comprise lymphomas of B-cell and T-cell origin. PM-NHLs are defined as involvement of mediastinal lymph nodes, thymus, and/or mediastinal organs (heart, lung, pleura, pericardium) by NHL without evidence of systemic disease at presentation. The clinical scenario is variable and depends on the lymphoma subtype. The radiologic presentation is also variable ranging from a mediastinal mass with or without superior vena cava syndrome, a pleural or a cardiac mass associated with effusion, or as an effusion only. The diagnosis of PM-NHLs can only be established by microscopic evaluation, and therefore, general pathologists should be aware of these tumors and familiar with their diagnostic approach. The most common anterior mediastinal NHLs (90% to 95%) are primary mediastinal (PM) large B-cell lymphoma and T-lymphoblastic lymphoma. Thymic marginal zone lymphoma and mediastinal gray zone lymphoma are very rare. The remainder PM-NHLs involving middle or posterior mediastinum include diffuse large B-cell lymphoma (DLBCL) and rare cases of T-cell lymphoma, including anaplastic large cell lymphoma and breast implant-associated anaplastic large cell lymphoma extending to the anterior mediastinum. Primary pleural and cardiac NHLs are mostly DLBCLs. Other rare subtypes of PM-NHLs include DLBCL associated with chronic inflammation/pyothorax-associated lymphoma, fibrin-associated DLBCL (both Epstein-Barr virus positive), and pleural and/or pericardial primary effusion lymphoma (human herpesvirus-8 positive/Epstein-Barr virus positive). We review the historical aspects, epidemiology, clinicoradiologic features, histopathology, immunohistochemistry, differential diagnosis, and relevant cytogenetic and molecular features of the remaining mediastinal B-cell lymphomas, including primary thymic marginal zone lymphoma of the mucosa-associated lymphoid tissue type, other PM small B-cell lymphomas, PM plasmacytoma, and the most relevant PM T-cell lymphomas.

Entities:  

Mesh:

Year:  2019        PMID: 31567129     DOI: 10.1097/PAP.0000000000000248

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  3 in total

Review 1.  Transformed diffuse large B-cell lymphoma from marginal zone lymphoma in the anterior mediastinum: A case report and review of the literature.

Authors:  Wataru Kitamura; Noboru Asada; Tetsuya Tabata; Rei Shibata; Tatsuya Nishi; Yuka Kato; Hiroki Takasuka; Hideaki Fujiwara; Daisuke Ennishi; Hisakazu Nishimori; Nobuharu Fujii; Ken-Ichi Matsuoka; Katsuyuki Kiura; Tadashi Yoshino; Yoshinobu Maeda
Journal:  J Clin Exp Hematop       Date:  2021-11-26

2.  Incidence, mortality, and survival analyses of patients with thymic lymphoma.

Authors:  Li Wang; Zhile Wang; Lanqing Huo; Ailin Zhao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

3.  Lymphoblastic lymphoma in two young siblings (coincidence or genetics?): two case reports.

Authors:  Naya Talal Hassan; Ebrahim Makhoul; Jafar Sallameh; Abdulmunem Ghanem; Samer Rajab; Waseem Ali; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.